Skip to main content
    C

    cbdMD Inc (YCBD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.36
    -0.00 (-0.94%)

    Market Cap: $4.88M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    cbdMD Inc (YCBD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    cbdMD (YCBD) has a market cap of $4.88M and an enterprise value of $4.62M. Its share count is up 83.57% from a year earlier. It kept -13.80% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 5.27% below the market cap, as cash exceeds debt.

    Market Cap$4.88M
    Enterprise Value$4.62M
    Latest price (Nov 17, 2026)$0.36

    Key Dates

    The next earnings report is expected on Dec 18, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateDec 18, 2026 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 1.66% in the quarter ended Jun 30, 2026.

    Shares Outstanding10.62M
    Shares Change (YoY)+83.57%
    Shares Change (QoQ)+1.66%

    Valuation Ratios

    Forward P/S0.2x
    P/B Ratio0.5x
    P/TBV Ratio0.6x

    Price Statistics

    The stock is down 43.99% over 52 weeks and trades 12.20% below its 50-day average.

    Beta (1Y)0.41
    52-Week Change-43.99%
    1-Month Change+3.30%
    3-Month Change-26.61%
    6-Month Change-52.05%
    5-Year Change-99.94%
    Total Return (1Y)-43.99%
    Total Return (3Y CAGR)-59.05%
    Total Return (5Y CAGR)-77.22%
    Max Drawdown (1Y)-84.67%
    Max Drawdown (3Y)-96.04%
    Sharpe Ratio (1Y)-0.40
    Correlation with SPY (1Y)0.04
    50-Day Average$0.41
    200-Day Average$0.64
    52-Week Range$0.33 to $2.56
    RSI (14 Days)40.5
    Average Volume (20 Days)171.59K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.50x current liabilities, and total debt is 0.23x shareholder equity.

    Current Ratio2.50x
    Quick Ratio1.37x
    Debt / Equity0.23x

    Returns and Efficiency

    ROA (5Y Average)-77.35%
    ROIC (5Y Average)-73.62%
    Asset Turnover1.82x

    Scores

    YCBD has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $20.93M over the last 12 months is up 10.01% from the 12 months before.

    Revenue$20.93M
    Revenue Growth (YoY)+10.01%
    Gross Profit$12.07M
    Operating Income-$2.90M
    Pretax Income-$2.89M
    Net Income-$2.89M
    EBITDA-$1.61M
    Reported EPS (TTM)-$0.31

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 62.43% of the $13.15M in total assets.

    Cash and Equivalents$2.12M
    Total Debt$1.86M
    Net Cash$257.02K
    Net Cash Per Share$0.02
    Working Capital$4.62M
    Shareholder Equity$8.21M
    Book Value Per Share$0.77
    Tangible Book Value$6.04M
    Tangible Book Per Share$0.57
    Total Assets$13.15M
    Total Liabilities$4.93M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $164.83M of capital spending, operating cash flow left -$167.05M of free cash flow.

    Operating Cash Flow-$2.22M
    Capital Expenditures$164.83M
    Free Cash Flow-$167.05M
    FCF Per Share-$14.91
    Depreciation and Amortization$246.74M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -13.87%, against a 5-year average of -77.31%.

    Gross Margin57.68%
    Operating Margin-13.87%
    Pretax Margin-13.80%
    Net Margin-13.80%
    EBITDA Margin-7.69%
    FCF Margin-798.06%
    Gross Margin (5Y Average)63.29%
    Operating Margin (5Y Average)-77.31%
    Net Margin (5Y Average)-75.03%

    Growth

    Revenue fell 18.46% a year over 3 years.

    Revenue Growth (3Y CAGR)-18.46%
    Revenue Growth (5Y CAGR)-14.45%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-8 reverse split on May 7, 2025.

    Last Split DateMay 7, 2025
    Split TypeReverse split
    Split Ratio1:8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About YCBD

    What is YCBD's market cap?

    cbdMD has a market cap of $4.88M. Its enterprise value, which adds debt and subtracts cash, is $4.62M.

    How many shares of YCBD are outstanding?

    cbdMD has 10.62M shares outstanding. The count is up 83.57% from a year earlier.

    Does YCBD pay a dividend?

    No. cbdMD does not pay a dividend.

    How much debt does YCBD have?

    cbdMD has $1.86M of total debt and $2.12M of cash and equivalents, a net cash position of $257.02K.